teva ceo

Teva share price struggles to recover following $6 billion market loss

The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.

By SHIRI HABIB-VALDHORN/GLOBES/TNS
18/02/2025

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.

By REUTERS
15/05/2023
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy